Detectable serum PSA after radical prostatectomy. Clinical and pathological relevance of perianastomotic biopsies

被引:0
|
作者
Minardi, D [1 ]
Galosi, AB [1 ]
Dell'Atti, L [1 ]
Yehia, M [1 ]
Muzzonigro, G [1 ]
机构
[1] Polytech Univ, Marche Med Sci, Inst Urol, Ancona, Italy
关键词
prostate specific antigen; radical prostatectomy; biochemical failure; perianastomotic biopsies; intraprostatic surgical margin;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Few reports have detailed the histopathological results of biopsies of the vesicourethral anastomosis or prostatic bed in patients with a detectable postoperative PSA. Patients and Methods: Among a series of 153 patients who underwent radical retropubic prostatectomies, we analyzed the results of 64 perianastomotic biopsies performed in 17 men with a detectable PSA and no evidence of local recurrence or distant metastases. Results: Fourteen of the 17 patients had a relapse of prostatic carcinoma; the results of histology in the three pT(2b)N(0)M(0) patients revealed the presence of benign prostatic hyperplasia in 2 patients and atypical cribriform proliferation in I patient. The first two patients are free from prostatic cancer recurrence 36 months after perianastomotic biopsies; a further biopsy performed 6 months after in the third patient showed the presence of prostatic carcinoma. Conclusion: The present study raises the possibility that residual benign tissue, resulting from unintentional disruption of the prostatic capsule during surgery, may be responsible for a detectable postoperative PSA. These cases comprise a histopathological classification described as "intraprostatic surgical margin".
引用
收藏
页码:1179 / 1185
页数:7
相关论文
共 50 条
  • [21] Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study
    Guillaume Ploussard
    Frédéric Staerman
    Jean Pierrevelcin
    Sébastien Larue
    Arnauld Villers
    Adil Ouzzane
    Cyrille Bastide
    Nicolas Gaschignard
    François Buge
    Christian Pfister
    Romain Bonniol
    Xavier Rebillard
    Saad Fadli
    Nicolas Mottet
    Fabien Saint
    Rodrigue Saad
    Jean-Baptiste Beauval
    Morgan Roupret
    François Audenet
    Mickaël Peyromaure
    Nicolas Barry Delongchamps
    Sébastien Vincendeau
    Tarek Fardoun
    Jérôme Rigaud
    Michel Soulie
    Laurent Salomon
    World Journal of Urology, 2014, 32 : 1331 - 1338
  • [22] Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study
    Ploussard, Guillaume
    Staerman, Frederic
    Pierrevelcin, Jean
    Larue, Sebastien
    Villers, Arnauld
    Ouzzane, Adil
    Bastide, Cyrille
    Gaschignard, Nicolas
    Buge, Francois
    Pfister, Christian
    Bonniol, Romain
    Rebillard, Xavier
    Fadli, Saad
    Mottet, Nicolas
    Saint, Fabien
    Saad, Rodrigue
    Beauval, Jean-Baptiste
    Roupret, Morgan
    Audent, Francois
    Peyromaure, Mickael
    Delongchamps, Nicolas Barry
    Vincendeau, Sebastien
    Fardoun, Tarek
    Rigaud, Jerome
    Soulie, Michel
    Salomon, Laurent
    WORLD JOURNAL OF UROLOGY, 2014, 32 (05) : 1331 - 1338
  • [23] SIGNIFICANCE OF RESIDUAL HYPERPLASTIC CELLS AFTER RADICAL PROSTATECTOMY. A LITERATURE REVIEW
    Ramirez-Backhaus, M.
    Trassierra, M.
    Pontones, J. L.
    Lujan, S.
    DiCapua, C.
    Rabenalt, R.
    Stolzenburg, J. U.
    Jimenez, Cruz F.
    ACTAS UROLOGICAS ESPANOLAS, 2008, 32 (09): : 873 - 878
  • [24] Impact of preoperative serum PSA level from 0 to 10 ng/ml on pathological findings and disease-free survival after radical prostatectomy
    Shekarriz, B
    Upadhyay, J
    Bianco, FJ
    Tefilli, MV
    Tiguert, R
    Gheiler, EL
    Grignon, DJ
    Pontes, JE
    Wood, DP
    PROSTATE, 2001, 48 (03) : 136 - 143
  • [25] Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
    Laurent Quero
    Pierre Mongiat-Artus
    Vincent Ravery
    Claude Maylin
    François Desgrandchamps
    Christophe Hennequin
    BMC Cancer, 8
  • [26] Pathological Concordance between Prostate Biopsies and Radical Prostatectomy Using Transperineal Sector Mapping Biopsies: Validation and Comparison with Transrectal Biopsies
    Marra, Giancarlo
    Eldred-Evans, David
    Challacombe, Ben
    Van Hemelrijck, Mieke
    Polson, Alexander
    Pomplun, Sabine
    Foster, Christopher S.
    Brown, Christian
    Cahill, Declan
    Gontero, Paolo
    Popert, Rick
    Muir, Gordon
    UROLOGIA INTERNATIONALIS, 2017, 99 (02) : 168 - 176
  • [27] CLEARANCE OF PSA AFTER RADICAL PROSTATECTOMY - A SUITABLE MODEL FOR CALCULATION OF PSA HALF-LIFE
    BRANDLE, E
    GOTTFRIED, HW
    MAIER, S
    FLOHR, P
    STEINBACH, G
    HAUTMANN, RE
    UROLOGE-AUSGABE A, 1995, 34 (05): : 419 - 423
  • [28] Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy
    Natsuo Tomita
    Takeshi Kodaira
    Kazuhisa Furutani
    Hiroyuki Tachibana
    Rie Nakahara
    Nobutaka Mizoguchi
    Norio Hayashi
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 1561 - 1567
  • [29] Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy
    Tomita, Natsuo
    Kodaira, Takeshi
    Furutani, Kazuhisa
    Tachibana, Hiroyuki
    Nakahara, Rie
    Mizoguchi, Nobutaka
    Hayashi, Norio
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (11) : 1561 - 1567
  • [30] PSA mass as a marker of prostate cancer progression after radical prostatectomy
    Bryniarski, Piotr
    Paradysz, Andrzej
    Fryczkowski, Mieczyslaw
    MEDICAL SCIENCE MONITOR, 2011, 17 (02): : CR104 - CR109